Three things to know:
1. The new reimbursement code for Anjeso is C9059. It is set to take effect July 1 for ASCs and hospital outpatient departments.
2. Baudax Bio announced the new pass-through status and commercial launch of Anjeso June 15.
3. Anjeso gained FDA approval earlier in the year, for use alone or in combination with non-steroidal anti-inflammatory drugs.
More articles on ASCs:
The ‘new normal’ for ASCs: 16 admins on how the pandemic will change the field forever
Dr. Thomas Vikoren: Same-day TJR ‘made all the more important’ by COVID-19
Indiana orthopedic practice with surgery center to open
